CClinicalTrials.gg
CompletedNCT03263351Updated Sep 23, 2025

Depression & Insulin Sensitivity in Adolescents

An interventional study of Cognitive-behavioral therapy group and Health education group in Type2 Diabetes, Type 2 Diabetes Mellitus and Insulin Sensitivity, sponsored by Colorado State University. Completed at 1 site in United States. Open to female participants aged 12 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-09-23.

Sponsored by Colorado State University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
147
Allocation
Randomized
Ages
12 Years to 17 Years
Sex
Female
01

Study summary

There has been a rise in type 2 diabetes (T2D) rates in adolescents, disproportionately in girls from disadvantaged racial/ethnic groups. This group of girls also is at heightened risk for depression, and depression and T2D are linked. Depressive symptoms are a risk factor for worsening of insulin sensitivity, one if the major precursors to T2D. In preliminary studies, the investigators found that a brief cognitive-behavioral therapy group decreased depressive symptoms and prevented worsening of insulin sensitivity in adolescent girls at-risk for T2D with moderate depressive symptoms. The aims of this study are: 1) to assess the efficacy of a cognitive-behavioral therapy depression group vs. a health education control group for improving insulin sensitivity and preserving insulin secretion in racially/ethnically diverse adolescent girls at-risk for T2D with moderate depressive symptoms over a 1-year follow-up; 2) to evaluate changes in eating, physical activity, and sleep as explanatory and 3) to test changes in cortisol factors as explanatory.

Read the detailed description

There has been rapid escalation of type 2 diabetes (T2D) rates in adolescents. Early-onset T2D (\<20y) typically shows a more aggressive course than adult-onset T2D and disproportionately affects girls from disadvantaged, racial/ethnic groups. This group of girls also is at heightened risk for depression, and depression and T2D are linked. Depressive symptoms often manifest in adolescence and are a prospective risk factor for worsening of insulin sensitivity, the major physiological precursor-in combination with deterioration of pancreatic β-cell capacity to secrete insulin-in the path to T2D. The effects of depression on poor insulin sensitivity remain even after accounting for adiposity. In theory, depressive symptoms may worsen insulin sensitivity through stress-induced behaviors (e.g., disinhibited eating, physical inactivity, sleep disturbance) and stress-induced physiological causal mechanisms (e.g., hypercortisolism). The central theme of this study is that intervening to reduce depressive symptoms in adolescents at-risk for T2D may offer an innovative, targeted approach to ameliorate insulin resistance and to, consequently, preserve β-cell function and lessen T2D risk. In preliminary data, the investigators found initial evidence that a 6-week cognitive-behavioral group decreased depressive symptoms and prevented worsening of insulin sensitivity 1 year later in overweight and obese girls with moderate depressive symptoms and a family history of T2D, in comparison to a 6-week health education control group. Directly extending these findings, the primary aims of this study are: 1) to assess the efficacy of a 6-week cognitive-behavioral depression group vs. a 6-week health education control group for improving insulin sensitivity and preserving β-cell function in racially/ethnically diverse adolescent girls at-risk for T2D with moderate depressive symptoms over a 1-year follow-up; 2) to evaluate changes in eating, physical activity, and sleep as behavioral explanatory mediators underlying the relationship between decreases in depressive symptoms and improvements in insulin sensitivity and β-cell function over 1 year and 3) to test changes in cortisol awakening response, diurnal cortisol rhythm, and total daily cortisol output as physiological mechanisms explaining the relationship between decreases in depressive symptoms and improvements in insulin sensitivity and β-cell function over 1 year.

02

Conditions studied

  • Type2 Diabetes
  • Type 2 Diabetes Mellitus
  • Insulin Sensitivity
  • Insulin Resistance
  • Depression
  • Adolescent Obesity
03

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female
  • Age 12-17 years
  • Body mass index (BMI) ≥85th percentile for age \& sex
  • Center for Epidemiologic Studies-Depression Scale (CES-D) >20
  • English speaking
  • ≥1 first- or second-degree family member with type 2 diabetes (T2D), prediabetes, or gestational diabetes
  • Good general health

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or breastfeeding
  • Type 2 diabetes as indicated by fasting glucose≥126 mg/dL or 2-hour glucose>200 mg/dL or Hba1c>=6.5
  • Medication affecting mood, weight, cortisol, or insulin sensitivity, including insulin sensitizers (e.g., metformin), anti-depressants, and stimulants
  • Major psychiatric disorder that, in the opinion of the investigators, would impede study compliance and necessitate more intensive treatment, including major depressive disorder, bipolar disorder, posttraumatic stress disorder, panic disorder, obsessive-compulsive disorder, schizophrenia, conduct disorder, alcohol and substance abuse, and anorexia/bulimia nervosa
  • Psychotherapy or structured weight loss program
  • Active suicidal ideation or suicidal behavior
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
147 participants (actual)

Study arms

  • Experimental
    Cognitive-behavioral therapy group

    Six-session cognitive-behavioral therapy group program designed as a prevention of depression intervention for adolescents at-risk for depression. The program is facilitated by a psychologist. Sessions are weekly for 1-hour.

    Behavioral: Cognitive-behavioral therapy group

  • Active comparator
    Health education group

    Six-session health education group program designed as a health education curriculum for teenagers. The program is facilitated by a psychologist. Sessions are weekly for 1-hour.

    Behavioral: Health education group

Interventions

  • BehavioralCognitive-behavioral therapy group

    Psychoeducation on depression; cognitive restructuring of negative thoughts; engagement in pleasant activities; healthy rewards; stress and coping.

    Also known as: Blues Program

  • BehavioralHealth education group

    Didactic health knowledge about interpersonal violence; basic nutrition guidance; sun safety; depression and signs of suicide; gang violence; substance use.

    Also known as: Hey-Durham

05

What researchers measure

Primary outcomes

  1. Depressive symptoms

    Center for Epidemiologic Studies-Depression Scale (CES-D) total score

    Time frame: 1-year

  2. Insulin sensitivity

    Whole body insulin sensitivity index estimated from 2-hour oral glucose tolerance test

    Time frame: 1-year

  3. Insulin secretion

    Oral disposition index estimated from 2-hour oral glucose tolerance test

    Time frame: 1-year

Secondary outcomes

  1. Disinhibited eating

    Emotional Eating Scale adapted for Children depression scale

    Time frame: 1-year

  2. Physical activity

    Moderate-to-vigorous physical activity by accelerometer

    Time frame: 1-year

  3. Physical inactivity

    Sedentary time by accelerometer

    Time frame: 1-year

  4. Sleep

    Sleep duration by actigraphy

    Time frame: 1-year

  5. Cortisol diurnal rhythm

    Salivary cortisol by home collection throughout the day

    Time frame: 1-year

  6. Daily cortisol output

    24-hour urine cortisol

    Time frame: 1-year

06

Study locations

1 site
  • Children's Hospital Colorado
    Aurora, Colorado 80045, United States
07

References and documents

Publications

  • Shomaker LB, Gulley L, Hilkin AM, Clark E, Annameier S, Rao S, Rockette-Wagner B, Kriska A, Wright KP Jr, Stice E, Nadeau KJ, Kelsey MM. Design of a randomized controlled trial to decrease depression and improve insulin sensitivity in adolescents: Mood and INsulin sensitivity to prevent Diabetes (MIND). Contemp Clin Trials. 2018 Dec;75:19-28. doi: 10.1016/j.cct.2018.10.007. Epub 2018 Oct 17. PubMed 30342256 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03263351
Lead sponsor
Colorado State University
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Advancing Translational Sciences (NCATS), Children's Hospital Colorado, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Sponsor
First posted
Aug 28, 2017
Start date
Oct 1, 2017
Primary completion
Mar 31, 2025
Completion
May 26, 2025
Last update
Sep 23, 2025

Study contacts

Lauren B Shomaker, PhD
principal investigator · Colorado State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion